Estimating treatment effects in clinical crossover trials
From MaRDI portal
Publication:4224605
DOI10.1080/10543409808835233zbMath0913.62103OpenAlexW2091227357WikidataQ52243004 ScholiaQ52243004MaRDI QIDQ4224605
Andrew P. Grieve, Stephen Senn
Publication date: 10 March 1999
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/10543409808835233
Applications of statistics to biology and medical sciences; meta analysis (62P10) Design of statistical experiments (62K99)
Related Items (2)
Cross-over trials in drug development: Theory and practice ⋮ Circular First- and Second-Order Balanced Repeated Measurements Designs
Cites Work
- Unnamed Item
- Use of baseline measurements in the two-period crossover design
- Optimal crossover designs for the comparison of two treatments in the presence of carryover effects and autocorrelated errors
- Neighbour balanced block designs for correlated errors
- Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
- A Bayesian Approach to Bioequivalence for the 2 x 2 Changeover Design
- 199. Note: On the Analysis of Simple Cross-Overs with Unequal Numbers of Replicates
This page was built for publication: Estimating treatment effects in clinical crossover trials
